Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
- DOI
- 10.1053/j.gastro.2013.07.051
- Published
- 2013 Nov
- Container
- Gastroenterology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1053/j.gastro.2013.07.051,
title = {Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.},
author = {Poordad F and Lawitz E and Reddy KR and Afdhal NH and Hézode C and Zeuzem S and Lee SS and Calleja JL and Brown RS Jr and Craxi A and Wedemeyer H and Nyberg L and Nelson DR and Rossaro L and Balart L and Morgan TR and Bacon BR and Flamm SL and Kowdley KV and Deng W and Koury KJ and Pedicone LD and Dutko FJ and Burroughs MH and Alves K and Wahl J and Brass CA and Albrecht JK and Sulkowski MS and Protocol 6086 Investigators},
year = {2013},
journal = {Gastroenterology},
doi = {10.1053/j.gastro.2013.07.051},
url = {https://doi.org/10.1053/j.gastro.2013.07.051}
}RIS
TY - JOUR TI - Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. AU - Poordad F AU - Lawitz E AU - Reddy KR AU - Afdhal NH AU - Hézode C AU - Zeuzem S AU - Lee SS AU - Calleja JL AU - Brown RS Jr AU - Craxi A AU - Wedemeyer H AU - Nyberg L AU - Nelson DR AU - Rossaro L AU - Balart L AU - Morgan TR AU - Bacon BR AU - Flamm SL AU - Kowdley KV AU - Deng W AU - Koury KJ AU - Pedicone LD AU - Dutko FJ AU - Burroughs MH AU - Alves K AU - Wahl J AU - Brass CA AU - Albrecht JK AU - Sulkowski MS AU - Protocol 6086 Investigators PY - 2013 JO - Gastroenterology DO - 10.1053/j.gastro.2013.07.051 UR - https://doi.org/10.1053/j.gastro.2013.07.051 ER -
APA
F, P., E, L., KR, R., NH, A., C, H., S, Z., SS, L., JL, C., Jr, B. R., A, C., H, W., L, N., DR, N., L, R., L, B., TR, M., BR, B., SL, F., KV, K., W, D., KJ, K., LD, P., FJ, D., MH, B., K, A., J, W., CA, B., JK, A., MS, S., & Investigators, P. 6. (2013). Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.. Gastroenterology. https://doi.org/10.1053/j.gastro.2013.07.051
Source records
- pubmed · retrieved 2026-09-26T02:25:50.125Z